Exercise occupies an unusual position in the longevity world as it rests on decades of epidemiology, physiology, clinical trials and public-health research. Walking, lifting weights, sprinting, swimming, stretching, yoga and tennis are all exercise, but they do not produce the same adaptations. A marathon runner can have extraordinary endurance and relatively little strength. A dedicated […]
Category: Non classé
A modern preventive health check-up can range from a few hundred euros for a focused cardiovascular and metabolic assessment to more than €15,000 for whole-body MRI, genomics, liquid biopsy, brain imaging and biological-age measurements. The difficult question is not how much can be measured. It is which measurements are likely to change a useful decision. […]
Categories
NMN Value analyis
One of Longevity’s Most Interesting Molecules NMN, or nicotinamide mononucleotide, occupies an unusual position in the longevity world because it sits at the intersection of an extremely compelling biological mechanism, a growing collection of human trials, prominent scientists and podcasters who have experimented with it personally, and a regulatory environment that is still trying to […]
Categories
Resveratrol value analysis
The Longevity Supplement That Started the Modern Debate Resveratrol is in some respects the original modern longevity supplement: a naturally occurring polyphenol found in grapes, berries, peanuts and other plants that moved from laboratory research into newspapers, podcasts, supplement cabinets and eventually large numbers of human clinical trials, largely because early work suggested that it […]
Categories
Credit Cards in Switzerland
Our favorite choices: Revolut for foreign currency purchases, Swisscards for cashback and add to that your shop, hotel or airline card as a bonus.
Prices have reached an unreasonable level at least in the U.S. and in some industries and sectors such as information technology (computers, semiconductors) and green technology where fundamentals no longer seem to matter and P/E ratios are often above 30. In other markets, Swiss, emerging or European, prices, although quite high, remain more reasonable.
Guide Finances 